Food allergy is a global problem. Peanut is one of the most common food allergens that can result in anaphylaxis, even with milligram exposure. Most peanut allergies could persist lifelong. The current standard of care for peanut allergy is strict dietary avoidance and immediate treatment of allergic reaction triggered by accident exposure. Oral immunotherapy (OIT) induces an increased reactivity threshold via modulation of the immune system. In recent years, peanut OIT has been developed to protect peanut-allergic individuals against severe or life-threating allergic reaction. This review discussed the update of the mechanism, efficacy, safety and impact on quality of life of peanut OIT for peanut allergy.
W Li, X Dong, G H Liu. The clinical advances of the peanut oral immunotherapy]. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 2021 May 06;55(5):592-597
PMID: 34034398
View Full Text